Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Oncoimmunology|January 12, 2026
Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort studyMaike Trommer, Alexander Rühle, Allison Lamrani, et al.
Frontiers in Immunology|February 18, 2026
Sex-specific differences in abscopal responses to combined radiotherapy and immune checkpoint inhibition-insights from a multicenter studyMaike Trommer, Alexander Rühle, Felix Ehret, et al.
Clinical and Translational Radiation Oncology|May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.
The Lancet. Oncology|December 22, 2025
O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trialAnca-Ligia Grosu, Wolfgang A Weber, Erika Graf, et al.
JAMA Network Open|January 14, 2026
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer TherapyEsmée L Looman, Stephanie G C Kroeze, Jana Schaule, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2026
Multicenter end-to-end evaluation of single-isocenter multitarget stereotactic radiosurgery approaches: accuracy and plan qualityBenedikt Thomann, Tobias Fechter, Johannes Fischer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 10, 2025
Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgeryBenedikt Thomann, Tobias Fechter, Johannes Fischer, et al.
Pageof 4